Tonix Pharmaceuticals Holding Corp. Forecast, price target & analysts
Tonix Pharmaceuticals Holding Corp. Target price 2025 - Analyst rating & recommendation
Tonix Pharmaceuticals Holding Corp. Classifications & Recommendation:
Tonix Pharmaceuticals Holding Corp. Price Target
| Target Price | $71.40 |
| Price | $34.89 |
| Potential |
104.64%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Tonix Pharmaceuticals Holding Corp. 2026 .
The average Tonix Pharmaceuticals Holding Corp. target price is $71.40.
This is
104.64%
register free of charge
$1,155.00
3,210.40%
register free of charge
$50.50
44.74%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Tonix Pharmaceuticals Holding Corp. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Tonix Pharmaceuticals Holding Corp. stock has an average upside potential 2026 of
104.64%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 10.09 | 11.27 |
| 29.86% | 11.70% | |
| Net Margin | -1,288.80% | -820.62% |
| 14.16% | 36.33% |
4 Analysts have issued a sales forecast Tonix Pharmaceuticals Holding Corp. 2025 . The average Tonix Pharmaceuticals Holding Corp. sales estimate is
This results in the following potential growth metrics:
4 Tonix Pharmaceuticals Holding Corp. Analysts have issued a net profit forecast 2025. The average Tonix Pharmaceuticals Holding Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -176.60 | -13.44 |
| 99.19% | 92.39% | |
| P/E | negative | |
| EV/Sales | 11.09 |
4 Analysts have issued a Tonix Pharmaceuticals Holding Corp. forecast for earnings per share. The average Tonix Pharmaceuticals Holding Corp. EPS is
This results in the following potential growth metrics and future valuations:
Tonix Pharmaceuticals Holding Corp....
Current Tonix Pharmaceuticals Holding Corp. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Noble Capital Markets |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Noble Capital Markets:
Locked
➜
Locked
|
Mar 20 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
